Odonate Therapeutics, Inc. General and Administrative Expense
Odonate Therapeutics, Inc. reported General and Administrative Expense of $11.15 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2021-11-10
- Odonate Therapeutics, Inc. general and administrative expense for the quarter ending 2021-09-30 was $11.15M, a 362.96% increase year-over-year.
- Odonate Therapeutics, Inc. general and administrative expense for the quarter ending 2021-06-30 was $3.43M, a 24.65% increase year-over-year.
- Odonate Therapeutics, Inc. general and administrative expense for the quarter ending 2021-03-31 was $2.89M, a 0.56% increase year-over-year.
- Odonate Therapeutics, Inc. general and administrative expense for the quarter ending 2020-12-31 was $2.36M, a 17.40% decline year-over-year.
- Odonate Therapeutics, Inc. general and administrative expense for fiscal 2020 was $10.39M, a 4.63% decline from fiscal 2019.
- Odonate Therapeutics, Inc. general and administrative expense for fiscal 2019 was $10.90M, a 0.74% increase from fiscal 2018.
- Odonate Therapeutics, Inc. general and administrative expense for fiscal 2018 was $10.82M, a 123.38% increase from fiscal 2017.
- Odonate Therapeutics, Inc. general and administrative expense for fiscal 2017 was $4.84M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2021-09-30 | $11.15M 10-Q · filed 2021-11-10 | $14.58M derived: sum of 2 quarters · filed 2021-11-10 | $17.47M 10-Q · filed 2021-11-10 | $19.83M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $3.43M 10-Q · filed 2021-07-27 | $6.32M 10-Q · filed 2021-07-27 | $8.68M derived: sum of 3 quarters · filed 2021-07-27 | $11.09M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | $2.89M 10-Q · filed 2021-05-14 | $5.25M derived: sum of 2 quarters · filed 2021-05-14 | $7.66M derived: sum of 3 quarters · filed 2021-11-10 | $10.41M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $4.77M derived: sum of 2 quarters · filed 2021-11-10 | $7.52M derived: sum of 3 quarters · filed 2021-11-10 | $10.39M 10-K · filed 2021-02-23 |
| 2020-09-30 | $2.41M 10-Q · filed 2021-11-10 | $5.16M derived: sum of 2 quarters · filed 2021-11-10 | $8.03M 10-Q · filed 2021-11-10 | $10.89M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $2.75M 10-Q · filed 2021-07-27 | $5.63M 10-Q · filed 2021-07-27 | $8.48M derived: sum of 3 quarters · filed 2021-07-27 | $11.15M derived: sum of 4 quarters · filed 2021-07-27 |
| 2020-03-31 | $2.87M 10-Q · filed 2021-05-14 | $5.73M derived: sum of 2 quarters · filed 2021-05-14 | $8.40M derived: sum of 3 quarters · filed 2021-05-14 | $11.18M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $5.52M derived: sum of 2 quarters · filed 2021-02-23 | $8.30M derived: sum of 3 quarters · filed 2021-02-23 | $10.90M 10-K · filed 2021-02-23 |
| 2019-09-30 | $2.67M 10-Q · filed 2020-10-28 | $5.45M derived: sum of 2 quarters · filed 2020-10-28 | $8.04M 10-Q · filed 2020-10-28 | $10.72M derived: sum of 4 quarters · filed 2020-10-28 |
| 2019-06-30 | $2.78M 10-Q · filed 2020-07-30 | $5.37M 10-Q · filed 2020-07-30 | $8.05M derived: sum of 3 quarters · filed 2020-07-30 | $11.01M derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | $2.59M 10-Q · filed 2020-04-28 | $5.27M derived: sum of 2 quarters · filed 2020-04-28 | $8.23M derived: sum of 3 quarters · filed 2020-04-28 | $10.99M derived: sum of 4 quarters · filed 2020-04-28 |
| 2018-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $5.64M derived: sum of 2 quarters · filed 2020-02-20 | $8.39M derived: sum of 3 quarters · filed 2020-02-20 | $10.82M 10-K · filed 2020-02-20 |
| 2018-09-30 | $2.96M 10-Q · filed 2019-11-06 | $5.71M derived: sum of 2 quarters · filed 2019-11-06 | $8.14M 10-Q · filed 2019-11-06 | $10.84M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $2.75M 10-Q · filed 2019-07-24 | $5.18M 10-Q · filed 2019-07-24 | $7.88M derived: sum of 3 quarters · filed 2019-07-24 | $9.13M derived: sum of 4 quarters · filed 2019-07-24 |
| 2018-03-31 | $2.42M 10-Q · filed 2019-04-25 | $5.13M derived: sum of 2 quarters · filed 2019-04-25 | $6.37M derived: sum of 3 quarters · filed 2019-04-25 | $6.99M derived: sum of 4 quarters · filed 2019-04-25 |
| 2017-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $3.95M derived: sum of 2 quarters · filed 2019-02-22 | $4.57M derived: sum of 3 quarters · filed 2019-02-22 | $4.84M 10-K · filed 2019-02-22 |
| 2017-09-30 | $1.25M 10-Q · filed 2018-10-23 | $1.86M derived: sum of 2 quarters · filed 2018-10-23 | $2.14M 10-Q · filed 2018-10-23 | |
| 2017-06-30 | $618.00K 10-Q · filed 2018-07-30 | $890.00K 10-Q · filed 2018-07-30 | ||
| 2017-03-31 | $272.00K 10-Q · filed 2018-05-03 |